Summary Platelet-derived endothelial cell growth factor (PD-ECGF) is identical to human thymidine phosphorylase (dThdPase). The human MCF-7 breast cancer cell line was transfected with the dThdPase cDNA and expressed a 45 kDa protein that was detected with anti-dThdPase antibody. Cell lysates possessed elevated dThdPase activity and cells had up to 165-fold increased sensitivity to the prodrug 5'-deoxy-5-fluorouridine (5'-DFUR) in vitro. Sensitivity to 5-fluorouracil (5-FU) and 5-fluoro-2'-deoxyuridine (5-FUdR) was unchanged. Recombinant dThdPase was shown to catalyse directly the phosphorolytic cleavage of 5'-DFUR to 5-FU. Exogenous thymidine (dThd) reversed the toxicity of 5-FUdR on the parental line (1 JAM dThd increased the IC50 value 1000-fold), but the dThd rescue was substantially modulated in the dThdPaseexpressing clone 4 (1 gM dThd raised the IC50 value 3-fold). We observed a substantial 'bystander' killing effect when small proportions of dThdPase-expressing cells were mixed with parental MCF-7 cells. dThdPase activity was on average 27-fold higher in breast tumours than in normal breast. The levels in wild-type MCF-7 are similar to the low end of the tumour expression. Thus, in some tumours resistance to 5'-DFUR therapy could be due to low dThdPase activity, and transfection to raise the dThdPase. levels within the broad tumour range or above it should markedly enhance sensitivity to the prodrug. These results confirm that dThdPase is a major pathway in the metabolic activation of 5'-DFUR, and the bystander effect suggests that this may be a suitable enzyme for gene therapy-directed enzyme/prodrug activation therapy.
Platelet-derived endothelial cell growth factor (PD-ECGF) was originally isolated from platelets through its unique mitogenic activity on endothelial cells (Miyazono et al., 1987; 1989) . It has since been shown to be homologous to human thymidine phosphorylase and a product of the same gene (Furukawa et al., 1992) . Thymidine phosphorylase (dThdPase) (EC 2.4.2.4.) catalyses the reversible phosphorolytic cleavage of thymidine (dThd) , deoxyuridine and their analogues to their bases and deoxyribose 1-phosphate (Iltzsch et al., 1985; el Kouni et al., 1993) . However, while evidence strongly implicates dThdPase in the metabolic activation of 5'-deoxy-5-fluorouridine (5'-DFUR) (Fujimoto et al., 1985) , no study has definitively demonstrated that pure human dThdPase can phosphorolytically cleave the glycosidic bond of the prodrug 5'-DFUR to yield 5-fluorouracil . We show here that elevated expression of dThdPase sensitises MCF-7 breast cancer cells to 5'-DFUR and this sensitisation is related to the capacity of dThdPase to cleave 5'-DFUR to 5-FU.
Breast, ovarian, colorectal and gastric cancers have been shown to express elevated levels of dThdPase relative to the normal surrounding tissue (Zimmerman et al., 1964; Yoshimura et al., 1990) . Increased dThdPase activity has also been found in the plasma of cancer patients compared with healthy controls (Pauly et al., 1977 (Pauly et al., , 1978 . This tumourassociated elevation of dThdPase activity has been exploited clinically through use of the prodrug 5'-DFUR. Yet success has been limited, possibly because of the heterogeneity of dThdPase activity within this group of carcinomas. Greater exploitation of this 'enzyme-prodrug activation' model could be achieved through the application of gene therapy techniques to direct the tissue-specific expression of dThdPase (Vile et al., 1993a) . For April 1995 small proportion of the tumour cell population to transiently express the construct (Vile et al., 1993b) .
We investigated the possibility that tumours expressing a low basal level of dThdPase activity might be further sensitised to 5'-DFUR through the transfection and expression of dThdPase, and whether elevated expression within a small proportion of the cell population could sensitise neighbouring tumour cells to the prodrug.
Comparative sensitivities of the parental and transfected cell lines to 5'-DFUR, 5-FU and 5-fluoro-2'-deoxyuridine (5-FUdR) were examined in the presence and absence of exogenous dThd. The presence of salvageable dThd within the microenvironment of a tumour could reduce the efficiency of the prodrug-enzyme system, since dThd will compete with its analogue 5'-DFUR for the active site of dThdPase, and limits its cytotoxic effects. Furthermore, dThdPase may enhance the toxicity of the active drug 5-FU, by deoxyribosyl transfer of 2'-deoxyribose 1-phosphate (Zimmerman et al., 1964; Krenitsky, 1968) , producing the deoxynucleoside 5-FUdR, which can form 5-FdUMP through the action of thymidine kinase, 5-FdUMP can inhibit thymidylate synthase, restricting de novo synthesis of dTMP, and can ultimately be fraudulently incorporated into DNA (Schwartz et al., 1992) . If the cytotoxic effects of 5-FU are mediated in part by this pathway, bioavailable dThd would diminish any inhibitory effects of thymidylate synthase inhibition. Thymine, dThd, ]-2,5-diphenyltetrazolium bromide) were purchased from Sigma (Dorset, UK). 5'-Deoxy-5-fluorouridine (5'-DFUR) was a kind gift from Dr Hideo Ishitsuka, Nippon Roche KK (Kanagawa, Japan). Assay of dThdPase activity Lysates were incubated for 16 h at 3TC in 10 mM dThd or 5'-DFUR and 10 mm potassium phosphate, pH 7.4. The reaction was terminated by addition of 0.7 ml of ice-cold sodium hydroxide (500 mM for dThd substrate, 20 mM for 5'-DFUR substrate) to 0.3 ml of reaction mixture, to produce a final solution pH of 13.3 and 12 respectively. Quenched samples were kept on ice, and the conversion of dThd to thymine and 5'-DFUR to 5-FU were measured spectrophotometrically at 300 nm and 305 nm respectively (Schwartz, 1978; Choong and Lee, 1985 Immunoblot analysis Samples of cells harvested for enzyme assays were washed in PBS buffer containing 1 mM phenylmethylsulphonyl fluoride, 1 mM benzamide, 50 Lg ml-' leupeptin and 50 lAg ml-' soyabean trypsin inhibitor. Cells were lysed in 1 ml of 2% SDS plus inhibitors in PBS at 65'C for 5 min. DNA was broken up with a fine-gauge needle passed up and down. Samples were stored at -20-C. Samples were resolved by 10% SDSpolyacrylamide gel electrophoresis, and proteins on the gel were electrophoretically transferred overnight to a nitrocellulose hybridisation transfer membrane. The membrane was washed with blocking buffer and incubated for 30 min with specific dThdPase rabbit antibody (dilution 1: 500). After washing, horseradish peroxidase-conjugated goat anti-rabbit antibody was incubated, and the membrane was developed using the enhanced chiluminescence Western blotting detection kit (Amersham, Buckinghamshire, UK).
Materials and methods

Chemicals
Resut dThdPase expression in MCF-7 cells Two clones, 4 and 7, were selected following transfection of MCF-7 cells with full-length dTbdPase cDNA. Cell lysates were prepared to examine the relative of dThdPase activity of the parental and transfected cell lines. The release of thymine from dThd and 5-FU from 5-DFUR were monitored spectroscopically at 300 nm and 305 nm respectively (Schwartz; 1978; Choong and Lee, 1985) . The observed enzyme activities of the lysates were compared with the in vitro sensitivity assays. The parental MCF-7 cells had some endogenous dThdPase activity, while clone 4 and clone 7 displayed a 90-and 7-fold increase in activity respectively (Table I) . Subsequent Western immunoblot analysis of the cell lysates confirmed that the clones expressed elevated levels of a 45 kDa protein that was detected by an anti-dThdPase antibody ( Figure 1 and clone 7 were 165 and 2.4 times higher than that of the parental line. The differing sensitivities of the cell lines were reflected in their relative levels of dThdPase activity with respect to the release of 5-FU from 5'-DFUR (Table I) (Figure 3a) .
Nevertheless, clone 4 cells were still markedly sensitised to 5'-DFUR compared with controls, and sufficiently high prodrug concentrations () 101AM) could overcome the dThdinduced reversal of toxicity. However, 1 -10 M dThd had no effect on the response of the parental line to 5'-DFUR (Figure 3b ). (Figure 6 ).
Two of the selected clones had elevated levels of dThdPase activity and expressed a 45 kDa protein that was detected with anti-dThdPase antibody. Increased expression of this enzyme sensitised the human MCF-7 breast cell line to 5'-DFUR in vitro. Clone 4, which showed a 90-fold increase in dThdPase activity (with respect to the release of thymine from dThd), had a 165-fold reduced IC50 value for 5'-DFUR compared with the parental line. Conversion of the prodrug 5'-DFUR to 5-FU by the cell lysate preparation of clone 4 was 67-fold greater than that of the parental line. Clone 7 had a 2.4-fold differential in the IC50 value for 5'-DFUR relative to the parental line. However, this difference was also reflected in the ability of the cell lysate to catalyse the formation of 5-FU from 5'-DFUR, being 5.6-fold greater than that of the parental line. The degree of sensitivity appears to be related to the capacity of the dThdPase to phosphorolytically cleave the prodrug 5'-DFUR to yield the metabolically active drug 5-FU. (Shaw et al., 1988a,b) . While the degree and extent of vascularisation of a solid tumour largely dictates the bioavailability of such nutrients, dThd availability in the microenvironment of a tumour may become elevated as a result of release from dying cells. Such increased bioavailability of dThd could modulate the efficacy of the prodrug 5'-DFUR by inhibiting the dThdPase-mediated cleavage to the active agent, 5-FU. However, we showed that even levels of dThd 50-to 100-fold greater than those detectable in plasma could not fully reverse the effect of 5'-DFUR, and 1M dThd had only a marginal effect. The cytotoxic effects of 5-FU are thought to be mediated, in part, by the inhibition of thymidylate synthase, through the anabolism of 5-FU to 5-FdUMP (Danenberg et al., 1974; Santi and McHenry.
Fue 6 Relative dThdPase actiVity (nmol thymine released h-'mg-' protein) of the parental MCF-7. clone 4 and 7 lysates relative to 12 breast tumour and ten normal breast cytosols. dThdPase activity was measured spectrophotometrically following 16 h incubation in 10 mm thymidine. 10 mm potassium phosphate pH 7.4 (37C). The total protein content of cytosols was determined against a high-grade BSA standard, using the BioRad protein dye assay. dThdPase activity and protein content were determined independently at least twice and the mean values are shown.
1972). However, the addition of 150 gM dThd did not influence the toxicity of 5-FU in the MCF-7 cell line, indicating that this is not an important mechanism of toxicity for MCF-7 cells (Kufe and Major, 1981) . Thus the observed reversal of 5'-DFUR toxicity by dThd in the clone 4 and 7 cell lines is mediated at the level of competition for prodrug activation, rather than modulating the cytotoxicity of the released 5-FU.
The IC50 values of 5-FUdR for the parental and transfected cell lines were not significantly different, suggesting that 5-FUdR is probably not an important substrate for the phosphorolytic activity of dThdPase. However, the dThdPase activity of the clones could significantly reverse the capacity of dThd to rescue the cells from the toxic effects of 5-FUdR (Nayak, 1992) . This suggests that the phosphorolytic breakdown of dThd by dThdPase renders it metabolically unavailable to bypass the inhibition of thymidylate synthase or to ultimately compete with 5-FdUTP for incorporation into DNA. Thus, it is possible that in vivo levels of dThdPase could contribute to 5-FUdR response. If so. these cases may respond well to 5'-DFUR treatment.
The requirement for dThdPase in the sensitisation to 5'-DFUR has recently been confirmed by transfecting dThdPase into human KB epidermoid carcinoma cells (Haraguchi et al., 1993) . We furthered this observation by establishing that recombinant dThdPase can catalyse the phoshorolytic cleavage of 5'-DFUR to release 5-FU. This takes account of potential differences between substrate specificity for the thymine-2'-deoxyriboside and the 5-fluorouracil-5'-deoxyriboside, and demonstrates a direct role for dThdPase in the sensitisation to 5'-DFUR. In contrast to the MCF-7 cell line, the KB epidermoid parental line expressed no endogenous dThdPase activity and the level of dThdPase activity conferred upon the clone by transfection was relatively low (168 nmol h-' mg-'). Another prodrug-enzyme-activated model, using the expression of cytosine deaminase to release 5-FU from the prodrug 5-fluorocytosine (Huber et al., 1993) (Houghton et al.. 1993 ). Furthermore. dThdPase may enhance the formation of FdUMP through the reversible addition of deoxyribose 1-phosphate to the enzymatically released 5-FU (Schwartz et al.. 1994) . Depletion of the available dThd would also serve to increase local concentrations of thymine. which would competitively inhibit the catabolism of 5-FU by dihydrouracil dehydrogenase. potentially extending its halflife within the tumour mass (Santelli and Valeroti. 1980) . Prolonging the duration and intensity of tumour tissue exposure to 5-FU. and its associated anabolites. has been shown to limit the occurrence of resistant clones associated with suboptimal chronic exposures in vitro (Sobrero et al.. 1993) . This may have implications in restricting the development of acquired resistance in vivo. Increasing the duration of 5-FU exposure has also been shown to enhance significantly the cytotoxicity of the biomodulators leucovorin and interferon x2a in vitro (Houghton et al., 1993) .
5'-DFUR. but not 5-FU. also possesses other antiproliferative-independent characteristics which may prove clinically advantageous. For example it has anti-cachectic activity (Tanaka et al.. 1990; Eda et al.. 1991) and has been reported to inhibit metastases in an artificial murine Lewis lung carcinoma metastasis model (Bertram. 1995) .
In conclusion, our results show that dThdPase is a candidate gene for gene-directed enzyme/prodrug therapy. and cell lines with endogenous dThdPase can be further sensitised to 5'-DFUR. This approach could also overcome one mechanism of 5-FUdR resistance. These data also suggest that selection of patients for 5'-DFUR therapy based on tumour levels of dThdPase should be considered. 
